According to new research, more than one-third of patients with NMOSD have evidence of cognitive dysfunction. Rates of cognitive dysfunction in NMOSD vary by race, education level, disability level, ...

Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in ...

Post-COVID-19 condition (PCC) involves persistent symptoms like fatigue and cognitive dysfunction, affecting 8.4% of US adults. A randomized clinical trial showed cognitive and behavioral ...

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction. As a result, many ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical study by a team of Weill Cornell Medicine ...

A recent neuropsychological evaluation diagnosis impugned several controversial theories about anesthesia and cognitive decline. As a medicinal therapy to relieve pain and brain dysfunction, ...

Hormonal dysregulation and gut microbiota alterations as potential contributors to cognitive dysfunction CHINA, March ...

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...

People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical study. People with dementia have protein build-up in ...